BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 3829206)

  • 41. Study of pathogenesis in twitcher mouse, an enzymatically authentic model of human Krabbe's disease.
    Inui K; Nishimoto J; Taniike M; Midorikawa M; Tsukamoto H; Okada S; Yabuuchi H
    J Inherit Metab Dis; 1989; 12 Suppl 2():383-5. PubMed ID: 2512450
    [No Abstract]   [Full Text] [Related]  

  • 42. Substrate reduction therapy for Krabbe's disease.
    Sands SA; LeVine SM
    J Neurosci Res; 2016 Nov; 94(11):1261-72. PubMed ID: 27638608
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Study of pathogenesis in twitcher mouse, an enzymatically authentic model of Krabbe's disease.
    Inui K; Nishimoto J; Taniike M; Midorikawa M; Tsukamoto H; Okada S; Yabuuchi H
    J Neurol Sci; 1990 Dec; 100(1-2):124-30. PubMed ID: 2128519
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Krabbe's disease: first trimester diagnosis confirmed on cultured amniotic fluid cells and fetal tissues.
    Giles L; Cooper A; Fowler B; Sardharwalla IB; Donnai P
    Prenat Diagn; 1987 Jun; 7(5):329-32. PubMed ID: 3615358
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Krabbe's globoid cell leukodystrophy: deficiency of galactocerebroside beta-galactosidase activity.
    Suzuki K; Suzuki Y
    J Neuropathol Exp Neurol; 1971 Jan; 30(1):145. PubMed ID: 5542535
    [No Abstract]   [Full Text] [Related]  

  • 46. Comparison of rates of hydrolysis of N-oleoyl and N-stearoyl glucocerebroside in patients with Gaucher's disease.
    Peters SP; Aquino L; Naccarato WF; Gilbertson JR; Diven WF; Glew RH
    Biochim Biophys Acta; 1979 Oct; 575(1):27-36. PubMed ID: 508779
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Beyond Krabbe's disease: The potential contribution of galactosylceramidase deficiency to neuronal vulnerability in late-onset synucleinopathies.
    Marshall MS; Bongarzone ER
    J Neurosci Res; 2016 Nov; 94(11):1328-32. PubMed ID: 27638614
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Alternate pathways of cerebroside catabolism.
    Lin YN; Radin NS
    Lipids; 1973 Dec; 8(12):732-6. PubMed ID: 4359203
    [No Abstract]   [Full Text] [Related]  

  • 49. [Biochemical diagnosis of globoid cell leukodystrophy (Krabbe's disease)].
    Tsvetkova IV; Zolotukhina TV; Rozenfel'd RA
    Vopr Med Khim; 1985; 31(2):128-30. PubMed ID: 2860752
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Tubules of globoid leukodystrophy: a right-handed helix.
    Yunis EJ; Lee RE
    Science; 1970 Jul; 169(3940):64-6. PubMed ID: 5463179
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Late juvenile-onset Krabbe's disease.
    Baker RH; Trautmann JC; Younge BR; Nelson KD; Zimmerman D
    Ophthalmology; 1990 Sep; 97(9):1176-80. PubMed ID: 2234850
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Of mice and men: or a mouse reveals the physiopathology of globoid cell leukodystrophy (Krabbe's disease)].
    Matthieu JM
    Rev Med Suisse Romande; 1990 Nov; 110(11):955-9. PubMed ID: 2267467
    [No Abstract]   [Full Text] [Related]  

  • 53. Galactosylceramide and galactosylsphingosine loading studies in cultured skin fibroblasts in human and murine globoid cell leukodystrophy.
    Ida H; Kusano K; Suzuki H; Tokoro T; Eto Y
    Biochem Biophys Res Commun; 1990 Jan; 166(2):1053-60. PubMed ID: 2302222
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical and biochemical heterogeneity of globoid cell leukodystrophy.
    Farrell DF; Swedberg K
    Ann Neurol; 1981 Oct; 10(4):364-8. PubMed ID: 7316489
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Additional deficiency of psychosine galactosidase in globoid cell leukodystrophy: an implication to enzyme replacement therapy.
    Miyatake T; Suzuki K
    Birth Defects Orig Artic Ser; 1973 Mar; 9(2):136-40. PubMed ID: 4611526
    [No Abstract]   [Full Text] [Related]  

  • 56. Recent developments in the biochemistry of globoid and metachromatic leucodystrophies.
    Farooqui AA; Mandel P
    Biomedicine; 1977 Jul; 26(4):232-6. PubMed ID: 21709
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Metabolism of cerebroside sulphate and subcellular distribution of its metabolites in cultured skin fibroblasts derived from controls, metachromatic leukodystrophy, globoid cell leukodystrophy and Farber disease.
    Inui K; Furukawa M; Nishimoto J; Okada S; Yabuuchi H
    J Inherit Metab Dis; 1987; 10(3):293-6. PubMed ID: 3123795
    [No Abstract]   [Full Text] [Related]  

  • 58. Use of a fluorescent analogue of galactocerebroside for assay of galactocerebroside beta-galactosidase activity in skin fibroblasts from patients with Krabbe's disease.
    Okada S; Kato T; Yabuuchi H; Yoshino K; Naoi M; Kiuchi K; Yagi K
    Clin Chim Acta; 1984 Jan; 136(1):57-63. PubMed ID: 6692566
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Suppression of galactocerebrosidase premature termination codon and rescue of galactocerebrosidase activity in twitcher cells.
    Luddi A; Crifasi L; Capaldo A; Piomboni P; Costantino-Ceccarini E
    J Neurosci Res; 2016 Nov; 94(11):1273-83. PubMed ID: 27638609
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Globoid cell leukodystrophy (Krabbe's disease): update.
    Suzuki K
    J Child Neurol; 2003 Sep; 18(9):595-603. PubMed ID: 14572137
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.